BZAM Ltd.

BZAM

CA12464X1015

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:48:53 2024-04-26 pm EDT			5-day change	1st Jan Change
0.015 ^CAD	0.00%		-50.00%	-88.00%

Jan. 25	BZAM Ltd. Announces Board Changes	CI
Jan. 25	BZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024	CI

An unknown buyer acquired Midway, BC facility of BZAM Ltd.

August 23, 2023

An unknown buyer acquired Midway, BC facility of BZAM Ltd. on August 4, 2023.

An unknown buyer completed the acquisition of Midway, BC facility of BZAM Ltd. on August 4, 2023.

Latest news about BZAM Ltd.

BZAM Ltd. Announces Board Changes	Jan. 25	CI
BZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024	Jan. 25	CI
BZAM Ltd. Enters into Second Amended and Restated Credit Agreement	Jan. 09	CI
BZAM Closes Purchase of Final Bell's Canadian Operation	Jan. 08	MT
BZAM Ltd. Announces Management Changes	Jan. 08	CI
BZAM Ltd. completed the acquisition of Final Bell Canada Inc. from Final Bell Holdings International Ltd.	Jan. 07	CI
BZAM Acquiring Final Bell Holdings' Canadian Units for C$13.5 Million in Shares	Dec. 06	MT
Toronto Stocks Edge Down; Roots Slides on Lower 3Q Profit, Revenue	Dec. 06	DJ
BZAM Agrees to Buy Final Bell's Canadian Operation	Dec. 06	MT
BZAM Ltd. entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. approximately CAD 13.5 million.	Dec. 05	CI
BZAM Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
BZAM Ltd. Secures Loan Facility from Chairman and Largest Shareholder's Investment Holding Company	23-10-30	CI
BZAM Ltd. announced that it expects to receive CAD 3 million in funding	23-10-29	CI
BZAM Ltd. cancelled the transaction announced on October 3, 2023	23-10-29	CI
BZAM Ltd. announced that it expects to receive CAD 2 million in funding	23-10-02	CI
BZAM Ltd. announced that it expects to receive CAD 2 million in funding from Clarus Securities Inc.	23-10-01	CI
An unknown buyer completed the acquisition of acquire Maple Ridge Facility of BZAM Ltd.	23-09-28	CI
BZAM Ltd. Provides Revenue Guidance for the Third Quarter of 2023	23-09-19	CI
BZAM Ltd. Reports Non-Cash Impairment Charge for Quarter Ended June 30, 2023	23-08-24	CI
BZAM Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
An unknown buyer acquired Midway, BC facility of BZAM Ltd.	23-08-23	CI
BZAM Ltd. completed the acquisition of additional 30.52% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.1 million.	23-08-09	CI
An unknown buyer completed the acquisition of Maple Ridge Facility of BZAM Ltd.	23-08-08	CI
North American Morning Briefing : Bank Results in -2-	23-07-14	DJ
BZAM Ltd. agreed to acquire additional 13.6% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.05 million.	23-07-12	CI

BZAM Ltd. is a Canadian cannabis producer with a focus on branded consumer goods. The Company's portfolio includes core brands, such as BZAM, TGOD, ness, Highly Dutch Organic, TABLE TOP, as well as partner brands Jeeter, Cookies, Sherbinskis, Dunn Cannabis, FRESH and Wyld. It operates facilities in British Columbia (BC), Alberta (AB), Ontario and Quebec, as well as retail stores in Regina, Saskatchewan. The Companyâs subsidiaries, The Green Organic Dutchman Ltd. (TGOD), BZAM Management Inc., Folium Life Science Inc. and BZAM Cannabis Corp., are licensed producers and hold licenses to produce cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts and edible cannabis and sell such cannabis products within Canada to provincially authorized retailers or distributors and federally licensed entities. Its product portfolio includes categories, such as Infused, Multi-packs, Edibles, Organic, and Craft.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
BZAM LTD.	-88.00%	2.97M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

BZAM Ltd.

Equities

BZAM

CA12464X1015

Pharmaceuticals

An unknown buyer acquired Midway, BC facility of BZAM Ltd.

Latest news about BZAM Ltd.

Chart BZAM Ltd.

Company Profile

Income Statement Evolution

Quarterly revenue - Rate of surprise

Sector Alternative Medicine